These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31753100)

  • 1. [A review on muscle-specific microRNAs as the biomarker for Duchenne muscular dystrophy].
    Meng Q; Lan D
    Zhongguo Dang Dai Er Ke Za Zhi; 2019 Nov; 21(11):1148-1152. PubMed ID: 31753100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating MicroRNAs in Duchenne Muscular Dystrophy.
    Mousa NO; Abdellatif A; Fahmy N; Zada S; El-Fawal H; Osman A
    Clin Neurol Neurosurg; 2020 Feb; 189():105634. PubMed ID: 31838454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy.
    Hrach HC; Mangone M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy.
    Coenen-Stass AML; Wood MJA; Roberts TC
    Trends Mol Med; 2017 Nov; 23(11):989-1001. PubMed ID: 28988850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model.
    Shibasaki H; Imamura M; Arima S; Tanihata J; Kuraoka M; Matsuzaka Y; Uchiumi F; Tanuma SI; Takeda S
    PLoS One; 2019; 14(1):e0211597. PubMed ID: 30699200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.
    Anaya-Segura MA; García-Martínez FA; Montes-Almanza LA; Díaz BG; Avila-Ramírez G; Alvarez-Maya I; Coral-Vazquez RM; Mondragón-Terán P; Escobar-Cedillo RE; García-Calderón N; Vazquez-Cardenas NA; García S; López-Hernandez LB
    Molecules; 2015 Jun; 20(6):11154-72. PubMed ID: 26091074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.
    Mankodi A; Bishop CA; Auh S; Newbould RD; Fischbeck KH; Janiczek RL
    Neuromuscul Disord; 2016 Oct; 26(10):650-658. PubMed ID: 27593185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
    Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
    Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
    Trifunov S; Natera-de Benito D; Exposito Escudero JM; Ortez C; Medina J; Cuadras D; Badosa C; Carrera L; Nascimento A; Jimenez-Mallebrera C
    Front Neurol; 2020; 11():304. PubMed ID: 32373058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy.
    Aránega AE; Lozano-Velasco E; Rodriguez-Outeiriño L; Ramírez de Acuña F; Franco D; Hernández-Torres F
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921834
    [No Abstract]   [Full Text] [Related]  

  • 18. miRNAs as serum biomarkers for Duchenne muscular dystrophy.
    Cacchiarelli D; Legnini I; Martone J; Cazzella V; D'Amico A; Bertini E; Bozzoni I
    EMBO Mol Med; 2011 May; 3(5):258-65. PubMed ID: 21425469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serum creatine kinase estimation with short tandem repeats based linkage analysis in carriers and affected children of Duchenne muscular dystrophy.
    Hashim R; Shaheen S; Ahmad S; Sattar A; Khan FA
    J Ayub Med Coll Abbottabad; 2011; 23(1):125-8. PubMed ID: 22830166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients.
    Awano H; Matsumoto M; Nagai M; Shirakawa T; Maruyama N; Iijima K; Nabeshima YI; Matsuo M
    Clin Chim Acta; 2018 Jan; 476():111-116. PubMed ID: 29175173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.